You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
高視醫療(02407.HK):角膜共聚焦顯微鏡取得國家醫療器械註冊證
格隆匯 04-09 19:07

格隆匯4月9日丨高視醫療(02407.HK)公吿,於近日,公司全資附屬公司高視創新科技有限公司("高視創新")自主研發的型號為T3-600及T3-400的角膜共聚焦顯微鏡取得由江蘇省藥品監督管理局批准的醫療器械註冊證。

該角膜共聚焦顯微鏡通過技術創新實現行業突破,成為國內同類設備中首款兼具寬視場與高分辨率。該設備採用激光光源和斷層共焦掃瞄技術,將掃瞄視場提升至600×600μm,光學分辨率達1.1μm及數字分辨率達0.4μm,顯著提高成像質量。角膜共聚焦顯微鏡可活體觀察角膜及結膜,輔助診斷多種角結膜疾病:感染性疾病、非感染性疾病包括角膜變性、營養不良、免疫性病變、圓錐角膜,以及手術相關、外傷、乾眼、全身病相關角膜病變等,為疾病診斷、病情評估提供依據。

高視創新已為T3產品規劃AI功能拓展路徑,後續將通過AI實現圖像自動分析等功能,提升診斷效率與精準度,同時T3產品已同步啟動CE註冊流程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account